Skip to main content
NCBI home page
Sarcoma logoLink to Sarcoma
. 2002 Mar;6(1):5–18. doi: 10.1080/13577140220127512

Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adults: A Clinical Practice Guideline

Alvaro Figueredo 1,✉, Vivien H C Bramwell 2, Robert Bell 2, Aileen M Davis 2, Manya L Charette 2, The members of the cancer care Ontario practice guidelines initiative sarcoma disease site group
PMCID: PMC2395488  PMID: 18521341

Abstract

Purpose. To review the literature and make recommendations for the use of anthracycline-based adjuvant chemotherapy in adult patients with soft tissue sarcoma (STS).

Patients. The recommendations apply to patients >15 years old with completely resected STS.

Methods. A systematic overview of the published literature was combined with a consensus process around the interpretation of the evidence in the context of conventional practice to develop an evidence-based practice guideline.

Results. Four meta-analyses and 17 randomized clinical trials comparing anthracycline-based adjuvant chemotherapy versus observation were reviewed. The Sarcoma Meta-Analysis Collaboration (SMAC) was the best analysis because it assessed individual patient data and had the longest follow-up. The results of the SMAC meta-analysis together with data from more recently published randomized trials, as well as our analysis of the toxicity and compliance data, are incorporated in this systematic review.

Discussion. It is reasonable to consider anthracycline-based adjuvant chemotherapy in patients who have had removal of a sarcoma with features predicting a high likelihood of relapse (deep location, size >5 cm, high histological grade). Although the benefits of adjuvant chemotherapy are most apparent in patients with extremity sarcomas, patients with high-risk tumours at other sites should also be considered for such therapy.

Full Text

The Full Text of this article is available as a PDF (181.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen A. The cardiotoxicity of chemotherapeutic drugs. Semin Oncol. 1992 Oct;19(5):529–542. [PubMed] [Google Scholar]
  2. Alvegård T. A., Sigurdsson H., Mouridsen H., Solheim O., Unsgaard B., Ringborg U., Dahl O., Nordentoft A. M., Blomqvist C., Rydholm A. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol. 1989 Oct;7(10):1504–1513. doi: 10.1200/JCO.1989.7.10.1504. [DOI] [PubMed] [Google Scholar]
  3. Antman K., Suit H., Amato D., Corson J., Wood W., Proppe K., Harmon D., Carey R., Greenberger J., Blum R. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. J Clin Oncol. 1984 Jun;2(6):601–608. doi: 10.1200/JCO.1984.2.6.601. [DOI] [PubMed] [Google Scholar]
  4. Bramwell V., Rouesse J., Steward W., Santoro A., Schraffordt-Koops H., Buesa J., Ruka W., Priario J., Wagener T., Burgers M. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1994 Jun;12(6):1137–1149. doi: 10.1200/JCO.1994.12.6.1137. [DOI] [PubMed] [Google Scholar]
  5. Brodowicz T., Schwameis E., Widder J., Amann G., Wiltschke C., Dominkus M., Windhager R., Ritschl P., Pötter R., Kotz R. Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial. Sarcoma. 2000;4(4):151–160. doi: 10.1155/2000/126837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Browman G. P., Levine M. N., Mohide E. A., Hayward R. S., Pritchard K. I., Gafni A., Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995 Feb;13(2):502–512. doi: 10.1200/JCO.1995.13.2.502. [DOI] [PubMed] [Google Scholar]
  7. Casper E. S., Gaynor J. J., Hajdu S. I., Magill G. B., Tan C., Friedrich C., Brennan M. F. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors. Cancer. 1991 Sep 15;68(6):1221–1229. doi: 10.1002/1097-0142(19910915)68:6<1221::aid-cncr2820680607>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  8. Chang A. E., Kinsella T., Glatstein E., Baker A. R., Sindelar W. F., Lotze M. T., Danforth D. N., Jr, Sugarbaker P. H., Lack E. E., Steinberg S. M. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol. 1988 Sep;6(9):1491–1500. doi: 10.1200/JCO.1988.6.9.1491. [DOI] [PubMed] [Google Scholar]
  9. Davis A. M., Kandel R. A., Wunder J. S., Unger R., Meer J., O'Sullivan B., Catton C. N., Bell R. S. The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol. 1997 Oct;66(2):81–87. doi: 10.1002/(sici)1096-9098(199710)66:2<81::aid-jso2>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  10. Edmonson J. H., Fleming T. R., Ivins J. C., Burgert E. O., Jr, Soule E. H., O'Connell M. J., Sim F. H., Ahmann D. L. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol. 1984 Dec;2(12):1390–1396. doi: 10.1200/JCO.1984.2.12.1390. [DOI] [PubMed] [Google Scholar]
  11. Figueredo A., Fine S., Maroun J., Walker-Dilks C., Wong S. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Cancer Prev Control. 1997 Oct;1(4):304–319. [PubMed] [Google Scholar]
  12. Frustaci S., Gherlinzoni F., De Paoli A., Bonetti M., Azzarelli A., Comandone A., Olmi P., Buonadonna A., Pignatti G., Barbieri E. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001 Mar 1;19(5):1238–1247. doi: 10.1200/JCO.2001.19.5.1238. [DOI] [PubMed] [Google Scholar]
  13. Gherlinzoni F., Bacci G., Picci P., Capanna R., Calderoni P., Lorenzi E. G., Bernini M., Emiliani E., Barbieri E., Normand A. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J Clin Oncol. 1986 Apr;4(4):552–558. doi: 10.1200/JCO.1986.4.4.552. [DOI] [PubMed] [Google Scholar]
  14. Glenn J., Kinsella T., Glatstein E., Tepper J., Baker A., Sugarbaker P., Sindelar W., Roth J., Brennan M., Costa J. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer. 1985 Mar 15;55(6):1206–1214. doi: 10.1002/1097-0142(19850315)55:6<1206::aid-cncr2820550612>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  15. Glenn J., Sindelar W. F., Kinsella T., Glatstein E., Tepper J., Costa J., Baker A., Sugarbaker P., Brennan M. F., Seipp C. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery. 1985 Mar;97(3):316–325. [PubMed] [Google Scholar]
  16. LeVay J., O'Sullivan B., Catton C., Bell R., Fornasier V., Cummings B., Hao Y., Warr D., Quirt I. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1091–1099. doi: 10.1016/0360-3016(93)90529-5. [DOI] [PubMed] [Google Scholar]
  17. Lerner H. J., Amato D. A., Savlov E. D., DeWys W. D., Mittleman A., Urtasun R. C., Sobel S., Shiraki M. Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol. 1987 Apr;5(4):613–617. doi: 10.1200/JCO.1987.5.4.613. [DOI] [PubMed] [Google Scholar]
  18. Lewis J. J., Benedetti F. Adjuvant therapy for soft tissue sarcomas. Surg Oncol Clin N Am. 1997 Oct;6(4):847–862. [PubMed] [Google Scholar]
  19. Mertens W. C., Bramwell V. H. Adjuvant chemotherapy for soft tissue sarcomas. Hematol Oncol Clin North Am. 1995 Aug;9(4):801–815. [PubMed] [Google Scholar]
  20. Noria S., Davis A., Kandel R., Levesque J., O'Sullivan B., Wunder J., Bell R. Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am. 1996 May;78(5):650–655. doi: 10.2106/00004623-199605000-00003. [DOI] [PubMed] [Google Scholar]
  21. Omura G. A., Blessing J. A., Major F., Lifshitz S., Ehrlich C. E., Mangan C., Beecham J., Park R., Silverberg S. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol. 1985 Sep;3(9):1240–1245. doi: 10.1200/JCO.1985.3.9.1240. [DOI] [PubMed] [Google Scholar]
  22. Rosenberg S. A., Tepper J., Glatstein E., Costa J., Young R., Baker A., Brennan M. F., Demoss E. V., Seipp C., Sindelar W. F. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 1983 Aug 1;52(3):424–434. doi: 10.1002/1097-0142(19830801)52:3<424::aid-cncr2820520307>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  23. Tierney J. F., Mosseri V., Stewart L. A., Souhami R. L., Parmar M. K. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer. 1995 Aug;72(2):469–475. doi: 10.1038/bjc.1995.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wilson A. N., Davis A., Bell R. S., O'Sullivan B., Catton C., Madadi F., Kandel R., Fornasier V. L. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994;30A(6):746–751. doi: 10.1016/0959-8049(94)90286-0. [DOI] [PubMed] [Google Scholar]
  25. van Oosterom A. T., Judson I., Verweij J., Stroobants S., Donato di Paola E., Dimitrijevic S., Martens M., Webb A., Sciot R., Van Glabbeke M. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet. 2001 Oct 27;358(9291):1421–1423. doi: 10.1016/s0140-6736(01)06535-7. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES